Vimian Group

Update in progress

VIMIAN.ST (Stockholm)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

Vimian Group AB (publ) is a global animal health company with four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. It offers Nextmune brand diagnostics and treatments for preventive care and chronic conditions in companion animals, and Indical Bioscience brand molecular and immunodiagnostics for veterinary labs. It also runs VetFamily, a member platform for clinics, and Movora surgical and dental products. Headquartered in Stockholm; founded 2020.

Company score

Sentiment: 0.06; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.18; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.15; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.09; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.08; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive